Statement on the Benefit Assessment of Etrasimod (ulcerative Colitis, ≥ 16 Years)

被引：0
|
作者：
Jansen, Petra Lynen
机构：
来源：
ZEITSCHRIFT FUR GASTROENTEROLOGIE | 2024年 / 62卷 / 10期
关键词：
INFLAMMATORY-BOWEL-DISEASE; CORTICOSTEROID-THERAPY; ECCO GUIDELINES; THERAPEUTICS;
D O I：
10.1055/a-2414-9330
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1857 / 1861
页数：5
相关论文
共 50 条
  • [31] Etrasimod for the Treatment of Ulcerative Colitis: Analysis of Infection Events from the ELEVATE UC Clinical Programme
    Regueiro, Miguel
    Siegmund, Britta
    Yarur, Andres J.
    Steinwurz, Flavio
    Gecse, Krisztina B.
    Goetsch, Martina
    Bhattacharjee, Abhishek
    Wu, Joseph
    Green, Jesse
    McDonnell, Aoibhinn
    Crosby, Catherine
    Lazin, Krisztina
    Branquinho, Diogo
    Modesto, Irene
    Abreu, Maria T.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 (10): : 1596 - 1605
  • [32] Statement of the German Society for Gastroenterology, Digestive and Metabolic Diseases on the GBA's Benefit Assessment of Active Substance Filgotinib (Indication: Ulcerative Colitis, previously treated Patients)
    Jansen, Petra Lynen
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2022, 60 (06): : 1047 - +
  • [33] PROLONGED BENEFIT OF FILGOTINIB IN PATIENTS WITH ULCERATIVE COLITIS IN SELECTION
    Beales, Ian
    Laharie, David
    Sturm, Andreas
    Kobayashi, Taku
    Matsumoto, Takayuki
    Oortwijn, Alessandra
    Jamoul, Corinne
    Faes, Margaux
    de Haas, Angela
    Vermeire, Severine
    GUT, 2023, 72 (SUPPL_2) : A75 - A75
  • [34] Benefit-Risk Assessment of Upadacitinib Treatment in Patients With Moderately to Severely Active Ulcerative Colitis
    Panaccione, Remo
    Blumenstein, Irina
    Irving, Peter
    Vladea, Ramona
    Ilo, Dapo
    Zhou, Wen
    Levy, Gweneth
    Yao, Xuan
    Dotan, Iris
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S553 - S554
  • [35] ULCERATIVE TRACHEOBRONCHITIS YEARS AFTER COLECTOMY FOR ULCERATIVE-COLITIS
    VASISHTA, S
    WOOD, JB
    MCGINTY, F
    CHEST, 1994, 106 (04) : 1279 - 1281
  • [36] Prolonged benefit of filgotinib in patients with Ulcerative Colitis in SELECTION
    Laharie, D.
    Sturm, A.
    Kobayashi, T.
    Matsumoto, T.
    Oortwijn, A.
    Jamoul, C.
    Faes, M.
    De Haas, A.
    Vermeire, S.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 819 - 820
  • [37] Ulcerative colitis in a child with partial trisomy 16
    Abell, Rebecca
    Difalco, Janet
    Morganstern, Jeffrey
    JOURNAL OF CROHNS & COLITIS, 2013, 7 (09): : E403 - E403
  • [38] Ulcerative Colitis in a Child With Partial Trisomy 16
    DiFalco, Janet
    Abell, Rebecca
    Morganstern, Jeffrey
    INFLAMMATORY BOWEL DISEASES, 2012, 18 : S68 - S69
  • [39] Assessment and Impact of Age on the Safety and Efficacy of Etrasimod in Patients With Ulcerative Colitis: A Post Hoc Analysis of Data From the ELEVATE UC Clinical Program
    Lichtenstein, Gary R.
    Allegretti, Jessica R.
    Loftus Jr, Edward, V
    Irving, Peter M.
    Banerjee, Rupa
    Charabaty, Aline
    Kuehbacher, Tanja
    Bananis, Eustratios
    Woolcott, John C.
    Dalam, Alexis B.
    Lazin, Krisztina
    Keating, Michael
    Mcdonnell, Aoibhinn
    Danese, Silvio
    INFLAMMATORY BOWEL DISEASES, 2025,
  • [40] ULCERATIVE-COLITIS - ASSESSMENT OF SEVERITY
    MANN, NS
    REDDY, AB
    MALHOTRA, KK
    NAZER, HM
    MILITARY MEDICINE, 1984, 149 (03) : 139 - 140
12345